PLD-402

N/A

Report date: 2023/08/01 18:01:57
NME

Base Information

Drug NamePLD-402
Drug Alias NamePLD-402
ClassificationOther
Mechanisms of ActionCapsid protein inhibitors
TargetsCapsid protein
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPelemed Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPelemed Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A